How much revenue does Novo Nordisk (NVO) generate?

Novo Nordisk (NVO) generated 309.06B DKK in total revenue for TTM through Q4 2025 with a net profit margin of 33.1%.

What is Novo Nordisk (NVO) gross profit margin?

Novo Nordisk (NVO) reported a gross profit margin of 81% for TTM through Q4 2025, equivalent to 250.28B DKK in gross profit. This means Novo Nordisk retains 81% of each revenue unit after direct costs of production.

What is Novo Nordisk (NVO) operating profit margin?

Novo Nordisk (NVO) reported an operating profit margin of 41.3% for TTM through Q4 2025, equivalent to 127.66B DKK in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.

What is Novo Nordisk (NVO) net profit margin?

Novo Nordisk (NVO) reported a net profit margin of 33.1% for TTM through Q4 2025, equivalent to 102.43B DKK in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.

How much does Novo Nordisk (NVO) invest in R&D?

Novo Nordisk (NVO) invested 52.04B DKK in research and development in TTM through Q4 2025 (16.8% of total revenue). R&D spending reflects investment in future products, services, and technologies.

How much does Novo Nordisk (NVO) spend on capital expenditures?

Novo Nordisk (NVO) spent 90.11B DKK on capital expenditures in TTM through Q4 2025 (29.2% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.

What is Novo Nordisk (NVO) free cash flow?

Novo Nordisk (NVO) generated 28.99B DKK in free cash flow for TTM through Q4 2025 (9.4% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.

What is Novo Nordisk (NVO) effective tax rate?

Novo Nordisk (NVO) had an effective tax rate of 21.5% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.

How Novo Nordisk (NVO) Makes Money: A Visual Guide

Novo Nordisk (NVO) generated 309.06B DKK in revenue, earning 102.43B DKK in net profit (33.1% margin). Below is an interactive breakdown of how revenue flows through the income statement.

Novo Nordisk (NVO) Income Statement Flow — TTM through Q4 2025

Calculated from the four most recent reported quarters, ending December 31, 2025 (reported February 3, 2026).

Frequently asked questions

How much revenue does Novo Nordisk (NVO) generate?: Novo Nordisk (NVO) generated 309.06B DKK in total revenue for TTM through Q4 2025 with a net profit margin of 33.1%.
What is Novo Nordisk (NVO) gross profit margin?: Novo Nordisk (NVO) reported a gross profit margin of 81% for TTM through Q4 2025, equivalent to 250.28B DKK in gross profit. This means Novo Nordisk retains 81% of each revenue unit after direct costs of production.
What is Novo Nordisk (NVO) operating profit margin?: Novo Nordisk (NVO) reported an operating profit margin of 41.3% for TTM through Q4 2025, equivalent to 127.66B DKK in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Novo Nordisk (NVO) net profit margin?: Novo Nordisk (NVO) reported a net profit margin of 33.1% for TTM through Q4 2025, equivalent to 102.43B DKK in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Novo Nordisk (NVO) invest in R&D?: Novo Nordisk (NVO) invested 52.04B DKK in research and development in TTM through Q4 2025 (16.8% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Novo Nordisk (NVO) spend on capital expenditures?: Novo Nordisk (NVO) spent 90.11B DKK on capital expenditures in TTM through Q4 2025 (29.2% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Novo Nordisk (NVO) free cash flow?: Novo Nordisk (NVO) generated 28.99B DKK in free cash flow for TTM through Q4 2025 (9.4% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.
What is Novo Nordisk (NVO) effective tax rate?: Novo Nordisk (NVO) had an effective tax rate of 21.5% for TTM through Q4 2025. This is the actual percentage of pre-tax income paid as income taxes.

Data & methodology

What is a Sankey diagram?: A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
How is the data calculated?: We use the income statement from company filings. For TTM (Trailing Twelve Months), we use a pre-aggregated twelve-month view aligned with our latest four quarterly periods. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
When was this data last updated?: Based on company filings through TTM through Q4 2025.